Erudio Healtherudio.com
Sponsor
Epizyme trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Epizyme yet. Erudio has found public clinician commentary on 3 clinical trials sponsored by Epizyme: E7438-G000-101, SYMPHONY-1 and SYMPHONY-2. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Epizyme, Inc.). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| SYMPHONY-1 NCT04224493 · Epizyme, Inc. StandardView → | relapsed/refractory follicular lymphoma | Phase 3 | Standard | View | |||
| SYMPHONY-2 NCT04762160 · Epizyme, Inc. FocusedView → | relapsed/refractory follicular lymphoma | Phase 2 | Focused | View | |||
| E7438-G000-101 NCT01897571 · Epizyme, Inc. FocusedView → | B-cell lymphomas and advanced solid tumors | Phase 1/Phase 2 | Focused | View | |||